newsfilter
← Latest News
GlobeNewswire·

Ziopharm Comments on Consent Solicitation Results

BOSTON, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP) (“Ziopharm” or the “Company”), today issued a statement in connection with the consent solicitation (the “Consent...